Dapagliflozin and Vildagliptin: A Complete Guide to Diabetes Management

DAPA VILDA SR is a two-drug fixed-dose combination for adults with type 2 diabetes mellitus. It brings dapagliflozin and vildagliptin together in one sustained release tablet and comes in two strengths:

• DAPA VILDA 10/100 SR: Dapagliflozin 10 mg + Vildagliptin SR 100 mg Tablets
• DAPA VILDA 5/100 SR: Dapagliflozin 5 mg + Vildagliptin SR 100 mg Tablets

Indications: What Is Dapagliflozin and Vildagliptin Used For?

The combination is meant to improve blood sugar control in adults with type 2 diabetes, alongside a healthy diet and regular physical activity. A doctor may consider it when:

1. Blood sugar is not well controlled on one medicine, such as metformin or a DPP-4 inhibitor, and a second mechanism is needed.
2. The patient already takes dapagliflozin and vildagliptin as separate tablets and a single tablet would be simpler.
3. Metformin is not tolerated or not suitable, and the doctor wants two complementary drugs that carry a low risk of hypoglycaemia.
4. Weight and blood pressure are also concerns, since dapagliflozin may help with both modestly.

It is not for type 1 diabetes or for treating diabetic ketoacidosis. The choice between the 10/100 and 5/100 strengths is made by the doctor based on blood sugar levels, kidney function, tolerance and overall health.

How Dapagliflozin and Vildagliptin Work Together

Type 2 diabetes is not a single problem. The pancreas releases insulin poorly after meals, the hormone glucagon stays too high, tissues respond weakly to insulin, and the kidneys keep reabsorbing glucose. These two medicines act on different parts of this picture.

Dapagliflozin: the SGLT2 inhibitor

Dapagliflozin blocks the sodium-glucose co-transporter 2 (SGLT2) in the kidney tubules. This protein normally returns filtered glucose to the bloodstream. When it is blocked, extra glucose leaves the body in urine. Because the action does not depend on insulin, it keeps working even when the pancreas is tiring out. Beyond sugar control, dapagliflozin is associated with modest weight loss and a small fall in blood pressure.

Vildagliptin: the DPP-4 inhibitor

Vildagliptin blocks the enzyme dipeptidyl peptidase-4 (DPP-4), which breaks down the gut hormones GLP-1 and GIP. With these hormones lasting longer, the pancreas releases more insulin when blood sugar rises after a meal, and glucagon release is reduced. This effect depends on glucose levels, so the risk of low blood sugar is small when it is not combined with insulin or a sulfonylurea.

Why the combination makes sense

• Vildagliptin works mainly on the pancreas and on the post-meal glucose rise.
• Dapagliflozin works on the kidneys and removes glucose through urine.
• The mechanisms do not overlap, so the effects add up.

A sustained release (SR) formulation releases vildagliptin gradually, which is why a 100 mg once-daily format is possible. Always follow the label of your specific product for how and when to take it.

Key Benefits of DAPA VILDA SR

1. Two complementary mechanisms in one tablet: Combining drugs from different classes usually lowers HbA1c more than either drug alone.

2. Low risk of hypoglycaemia: Neither component forces insulin release regardless of blood glucose, so low sugar episodes are uncommon unless insulin or a sulfonylurea is also used.

3. Possible modest weight reduction: Dapagliflozin causes calorie loss through urinary glucose, and vildagliptin is generally weight-neutral.

4. Mild blood pressure lowering: SGLT2 inhibitors have a small diuretic effect that can lower systolic blood pressure by a few mmHg.

5. Heart and kidney relevance: Dapagliflozin has been studied in large outcome trials in heart failure and chronic kidney disease. Whether these wider benefits apply to you is a decision for your doctor.

6. Simpler routine: One tablet in place of two can reduce the pill burden and help people stay consistent with treatment.

Efficacy and Clinical Evidence

The evidence below is for the individual ingredients and for the SGLT2 inhibitor plus DPP-4 inhibitor approach. Brand-specific results should always be confirmed against the approved prescribing information.

Dapagliflozin 10 mg

• In randomised trials in adults with type 2 diabetes, dapagliflozin 10 mg lowered HbA1c by roughly 0.5% to 0.8% versus placebo when added to other therapy, with weight reductions of around 2 to 3 kg.
• DECLARE-TIMI 58 studied more than 17,000 patients with type 2 diabetes and found a lower rate of hospitalisation for heart failure.
• DAPA-HF showed benefit in heart failure with reduced ejection fraction, including patients without diabetes.
• DAPA-CKD showed benefit in chronic kidney disease, again including patients without diabetes.
• Its blood sugar lowering effect weakens as kidney function falls, so it is less useful for glucose control at low eGFR.

Vildagliptin 100 mg

• Vildagliptin alone or with metformin lowers HbA1c by about 0.7% to 1.0% in many studies, with a low rate of hypoglycaemia.
• The VERIFY study (The Lancet, 2019) found that early combination of vildagliptin with metformin in newly diagnosed type 2 diabetes delayed the time to first treatment failure compared with starting metformin alone and adding drugs later.
• Vildagliptin is widely used in India and many other countries, but it is not approved in the United States.

The SGLT2 plus DPP-4 combination

Studies pairing an SGLT2 inhibitor with a DPP-4 inhibitor have shown additional HbA1c reduction and body weight benefit compared with either drug alone, with safety in line with the individual medicines. Published trials specifically of a fixed-dose dapagliflozin and vildagliptin tablet are more limited than those for the separate components, so the clinical picture largely rests on the evidence for each drug and on the logic of combining their mechanisms. Individual response varies.

Dosage and How to Take DAPA VILDA SR

• Take it exactly as your doctor has prescribed, usually once daily.
• Swallow the sustained release tablet whole with water. Do not crush, break or chew it.
• Do not switch between 10/100 and 5/100 on your own.
• If you miss a dose, take it when you remember unless the next dose is close. Never take two doses together.
• Keep drinking enough fluids during treatment.

Who Should Not Take It

Avoid this medicine if you:

• Are allergic to dapagliflozin, vildagliptin or any other ingredient.
• Have type 1 diabetes or have had diabetic ketoacidosis.
• Have significant liver disease.
• Have severe kidney impairment or are on dialysis.
• Have had pancreatitis, unless your doctor decides otherwise.

Precautions and Warnings

Kidney function: Kidney tests are needed before starting and periodically afterward. Vildagliptin dosing is often reduced in moderate to severe kidney impairment, and dapagliflozin’s glucose-lowering effect declines at lower eGFR, so a fixed 100 mg vildagliptin combination may not suit everyone.

Liver function: Vildagliptin has been linked with rare liver enzyme elevations. Liver tests are generally advised before starting and at intervals during the first year.

Ketoacidosis: SGLT2 inhibitors can cause diabetic ketoacidosis, sometimes with near-normal blood sugar. Nausea, vomiting, stomach pain, rapid breathing and unusual tiredness need urgent medical attention. Tell your doctor before surgery, prolonged fasting or serious illness, as the medicine may have to be paused.

Genital and urinary infections: Glucose in the urine can encourage genital yeast infections and urinary tract infections. A rare but serious infection of the genital and perineal area (Fournier’s gangrene) has been reported with SGLT2 inhibitors. Pain, redness or swelling in that area needs immediate review.

Dehydration and low blood pressure: The mild diuretic effect can cause dizziness, especially in older adults, in hot weather or during vomiting and diarrhoea.

Pancreatitis: Severe, persistent stomach pain, sometimes spreading to the back, should be reported immediately.

Heart failure: Vildagliptin has limited experience in severe heart failure, so your doctor will weigh this if you have it.

Skin and swelling reactions: Blistering skin conditions have been reported with DPP-4 inhibitors. Angioedema is possible, with a higher risk in people also taking ACE inhibitors.

Alcohol: Heavy drinking can increase the risk of ketoacidosis and low blood sugar.

Possible Side Effects

Common: increased urination, genital itching or yeast infection, urinary tract infection, headache, dizziness, nausea, mild stomach discomfort and joint pain.

Serious but less common: ketoacidosis, pancreatitis, liver problems, severe infections around the genitals, severe skin reactions, and signs of allergy such as swelling of the face or throat, rash or difficulty breathing. Seek emergency help if any of these occur.

Lifestyle Tips During Treatment

• Follow a balanced, portion-controlled diet and cut back on sugary foods and drinks.
• Stay active. About 150 minutes of brisk activity a week is a common target if your doctor agrees.
• Check blood sugar and HbA1c as advised.
• Maintain genital hygiene and drink plenty of water.
• Do not stop treatment on your own, even when your readings improve.

How It Compares with Other Options

You may also come across vildagliptin 100 mg with metformin 500 mg, or triple combinations that add metformin. A dapagliflozin and vildagliptin tablet suits people who need two complementary mechanisms without metformin, or who already take metformin separately and want to avoid adding more tablets. The right choice depends on kidney function, tolerance, weight, cardiovascular risk and cost, which is why a doctor’s assessment matters.

Storage

Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children. Do not use after the expiry date.

Frequently Asked Questions 

1. What is DAPA VILDA SR used for?
DAPA VILDA SR is used with diet and exercise to control blood sugar in adults with type 2 diabetes. It contains dapagliflozin and vildagliptin.

2. What is dapagliflozin and vildagliptin used for?
This combination lowers blood sugar in type 2 diabetes by working on the kidneys and the pancreas through two different mechanisms.

3. What is dapagliflozin 10 mg used for?
Dapagliflozin 10 mg lowers blood sugar by making the kidneys pass extra glucose in urine. Doctors also use it in some patients with heart failure or chronic kidney disease.

4. What is vildagliptin 100 mg used for?
Vildagliptin 100 mg helps the pancreas release insulin after meals and lowers glucagon, which reduces blood sugar in type 2 diabetes.

5. What are the uses of dapagliflozin and vildagliptin sustained release tablets?
They are used to improve glycaemic control in adults with type 2 diabetes, with the sustained release form allowing gradual drug release.

6. What is the difference between DAPA VILDA 10/100 SR and 5/100 SR?
Both contain vildagliptin SR 100 mg. The difference is dapagliflozin, which is 10 mg in one and 5 mg in the other.

7. How do dapagliflozin and vildagliptin work together?
Dapagliflozin removes glucose through urine, while vildagliptin improves meal-time insulin release. Their actions complement each other.

8. Does DAPA VILDA SR cause weight loss?
Some people lose a small amount of weight, mainly because of dapagliflozin. It is not a weight-loss drug, and results vary.

9. Can this medicine cause low blood sugar?
The risk is low on its own, but it increases if you also use insulin or a sulfonylurea, skip meals or drink heavily.

10. When should I take DAPA VILDA SR?
Take it as your doctor prescribes, usually once daily. Swallow it whole and do not crush or chew it.

11. What are the common side effects?
Increased urination, genital or urinary infections, headache, dizziness, nausea and joint pain are among the more common ones.

12. Who should not take dapagliflozin and vildagliptin?
People with type 1 diabetes, diabetic ketoacidosis, significant liver disease, severe kidney impairment or an allergy to either ingredient should not take it.

13. Is it safe for kidney patients?
It depends on kidney function. Both drugs need dose or use adjustments when eGFR is reduced, so your doctor will check kidney tests first.

14. What is the role of vildagliptin 100 mg with metformin 500 mg?
It is another common combination in which a DPP-4 inhibitor is paired with metformin. DAPA VILDA SR pairs vildagliptin with dapagliflozin instead.

15. Can I take it with metformin?
Doctors sometimes combine it with metformin, but this must be decided by your doctor, who will adjust the plan to your needs.

Conclusion

DAPA VILDA 10/100 SR and DAPA VILDA 5/100 SR combine dapagliflozin and vildagliptin in one sustained release tablet for adults with type 2 diabetes. Dapagliflozin removes excess glucose through the kidneys, while vildagliptin supports the pancreas’s response to meals. Together they can improve glycaemic control with a low hypoglycaemia risk and possible modest benefits for weight and blood pressure, while reducing the number of tablets to take. They also carry real risks, including ketoacidosis, genital and urinary infections, dehydration, liver effects and pancreatitis, so regular check-ups and open communication with your doctor are important. This is a prescription medicine and should only be started, adjusted or stopped under medical supervision.

For Further More Information:  

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +918824175417, +919982524671

Buy Now